BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 12668915)

  • 1. Pharmacogenetics of hepatocellular transporters.
    Pauli-Magnus C; Meier PJ
    Pharmacogenetics; 2003 Apr; 13(4):189-98. PubMed ID: 12668915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular transporters and cholestasis.
    Pauli-Magnus C; Meier PJ
    J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S103-10. PubMed ID: 15758645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatobiliary transport.
    Kullak-Ublick GA; Beuers U; Paumgartner G
    J Hepatol; 2000; 32(1 Suppl):3-18. PubMed ID: 10728790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatobiliary transporters and drug-induced cholestasis.
    Pauli-Magnus C; Meier PJ
    Hepatology; 2006 Oct; 44(4):778-87. PubMed ID: 17006912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of cholestasis.
    Zollner G; Trauner M
    Wien Med Wochenschr; 2006 Jul; 156(13-14):380-5. PubMed ID: 16937039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New molecular aspects of cholestatic liver diseases].
    Trauner M; Fickert P; Stauber RE
    Z Gastroenterol; 1999 Jul; 37(7):639-47. PubMed ID: 10458013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholestasis: the ABCs of cellular mechanisms for impaired bile secretion--transporters and genes.
    Shaffer EA
    Can J Gastroenterol; 2002 Jun; 16(6):380-9. PubMed ID: 12096302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of drug transporter pharmacogenetics on cholestasis.
    Dietrich CG; Geier A
    Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1533-51. PubMed ID: 25260651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Function and regulation of ATP-binding cassette transport proteins involved in hepatobiliary transport.
    Hooiveld GJ; van Montfoort JE; Meijer DK; Müller M
    Eur J Pharm Sci; 2000 Nov; 12(1):13-30. PubMed ID: 11121730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in the Molecular Characterization of Hepatobiliary Transporters.
    Keppler D
    Dig Dis; 2017; 35(3):197-202. PubMed ID: 28249282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.
    Stieger B
    Handb Exp Pharmacol; 2011; (201):205-59. PubMed ID: 21103971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis.
    Keitel V; Burdelski M; Warskulat U; Kühlkamp T; Keppler D; Häussinger D; Kubitz R
    Hepatology; 2005 May; 41(5):1160-72. PubMed ID: 15841457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From blood to bile: recent advances in hepatobiliary transport.
    Arrese M; Accatino L
    Ann Hepatol; 2002; 1(2):64-71. PubMed ID: 15115970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of hepatobiliary transport systems in health and disease: implications for a rationale approach to the treatment of intrahepatic cholestasis.
    Wagner M; Trauner M
    Ann Hepatol; 2005; 4(2):77-99. PubMed ID: 16010241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical application of transcriptional activators of bile salt transporters.
    Baghdasaryan A; Chiba P; Trauner M
    Mol Aspects Med; 2014 Jun; 37(100):57-76. PubMed ID: 24333169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model Systems for Studying the Role of Canalicular Efflux Transporters in Drug-Induced Cholestatic Liver Disease.
    Stieger B; Mahdi ZM
    J Pharm Sci; 2017 Sep; 106(9):2295-2301. PubMed ID: 28385542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New molecular features of cholestatic diseases of the liver].
    Méndez-Sánchez N; Chavez-Tapia NC; Uribe M
    Rev Invest Clin; 2003; 55(5):546-56. PubMed ID: 14968476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.
    Zollner G; Fickert P; Zenz R; Fuchsbichler A; Stumptner C; Kenner L; Ferenci P; Stauber RE; Krejs GJ; Denk H; Zatloukal K; Trauner M
    Hepatology; 2001 Mar; 33(3):633-46. PubMed ID: 11230744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis.
    Trauner M; Wagner M; Fickert P; Zollner G
    J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S111-24. PubMed ID: 15758646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function.
    Shoda J; Kano M; Oda K; Kamiya J; Nimura Y; Suzuki H; Sugiyama Y; Miyazaki H; Todoroki T; Stengelin S; Kramer W; Matsuzaki Y; Tanaka N
    Am J Gastroenterol; 2001 Dec; 96(12):3368-78. PubMed ID: 11774951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.